|
| Press Releases |
|
 |
|
| Tuesday, April 30, 2024 |
|
|
New Immuno-Oncology Research Project in Partnership With Merck Starts at the BioMed X Institute in Heidelberg |
| BioMed X, a German biomedical research institute, announces the start of a new research project in partnership with Merck at its site in Heidelberg, Germany. The main objective of the project is to develop novel immunotherapeutic strategies to overcome the immunosuppressive microenvironment of solid tumors. more info >> |
|
| Thursday, October 5, 2023 |
|
|
Electronics Asia Conference 2023 to Highlight IoT, AI/ML, Automotive, and Wireless Developments Driving Semiconductor Industry Growth in Asia |
| Following the huge success of its inaugural edition, the Electronics Asia Conference (EAC), a virtual conference and exhibition organized by AspenCore, the publisher of EE Times Asia, EE Times India, and EDN Asia, is set to take place from October 17 to 19, 2023. more info >> |
|
| Tuesday, April 4, 2023 |
|
|
BioMed X and Merck Expand Collaboration Aiming to Leverage Cancer-Specific Vulnerabilities for Targeted Therapies |
| BioMed X, an independent biomedical research institute, announces the start of its new research project - "New Strategies to Enhance the Immunogenicity of Tumors" - in collaboration with Merck. The focus of this new research group will be to develop novel approaches for enhancing tumor immunogenicity to broaden the population of patients who could benefit from cancer immunotherapy. more info >> |
|
| Monday, September 12, 2022 |
|
|
Eisai and Merck & Co., Inc. Present Results from Phase 3 LEAP-002 Trial Evaluating LENVIMA (lenvatinib) Plus KEYTRUDA (pembrolizumab) Versus LENVIMA Monotherapy in Patients With Unresectable Hepatocellular Carcinoma |
| Eisai and Merck & Co., Inc., Rahway, NJ, USA (known as MSD outside of the United States and Canada) today announced the first presentation of results from the final analysis of the Phase 3 LEAP-002 trial investigating LENVIMA, the orally available multiple receptor tyrosine kinase inhibitor discovered by Eisai, plus KEYTRUDA. more info >> |
|
| Thursday, August 13, 2020 |
|
|
QBiotics Announces Clinical Collaboration with MSD Targeting Unresectable Melanoma |
| QBiotics Group Limited (QGL), a life sciences company developing novel anticancer and wound healing pharmaceuticals, has entered into an agreement with MSD (tradename of Merck & Co., Inc., Kenilworth, NJ, USA), to evaluate use of its lead molecule tigilanol tiglate, in combination with Keytruda(R) (pembrolizumab) in patients with unresectable melanoma. more info >> |
|
| Tuesday, September 29, 2009 |
|
|
Next Generation Technologies to Boost Efficiency and Safety for Asia's Chemical Industries; Latest in Process Engineering, Controls, Instrumentation and Scientific Equipment at CIA2009 |
| CIA2009, Asia's leading process engineering, controls instrumentation and scientific equipment exhibition gathers the latest technologies and solutions that caters to industry demands to enhance product quality and expand production capacity while improving process safety and plant availability. more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
SMBC and Fujitsu partner towards creation of AI-powered data analytics business
Apr 3, 2025 22:10 JST
|
|
|
AI Paradox in QA: Twice as Many Testers Fear Job Loss, But Adoption Keeps Climbing 
Apr 3, 2025 20:06 HKT/SGT
|
|
|
The India Market Entry Dilemma: What's Holding Manufacturers Back
Apr 3, 2025 19:30 HKT/SGT
|
|
|
Connect Marketplace Hong Kong 2025 Concludes Successfully
Apr 3, 2025 18:29 HKT/SGT
|
|
|
JBM Healthcare Completes Acquisition of 90% Interest in Tin Hee Tong
Apr 3, 2025 17:30 HKT/SGT
|
|
|
Guinean Artist Elie Kamano to Release New Single Exploring Africa's Colonial Past
Apr 3, 2025 17:00 HKT/SGT
|
|
|
Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025
Apr 3, 2025 17:00 HKT/SGT
|
|
|
Asiaray Achieves Net Profit Turnaround of RMB10.4 Million in 2024
Apr 3, 2025 16:41 HKT/SGT
|
|
|
JF SmartInvest Holdings Ltd Announces 2024 Annual Results
Apr 3, 2025 15:59 HKT/SGT
|
|
|
AEON CREDIT SERVICE (ASIA) COMPANY LIMITED FY2024/25 Revenue Up to HK$1,759.3 million with Net Profit of HK$400.5 million
Apr 3, 2025 14:04 HKT/SGT
|
|
|
Prideone Entertainment Announces New Post-War Film to Commemorate the 80th Anniversary of World War II's End
Apr 3, 2025 7:00 JST
|
|
|
3rd Future Cross Border Payments Summit, Dubai 2025: Trends Shaping the Future of Payments
Apr 2, 2025 22:03 HKT/SGT
|
|
|
Doubleview Gold Corp 2025 Exploration Program
Apr 2, 2025 21:00 HKT/SGT
|
|
|
Hola Prime Launches Industry-First One-on-One Mentorship from Market Experts
Apr 2, 2025 20:00 HKT/SGT
|
|
|
Innovation Beverage Group Expands U.S. Distribution of its Award-Winning Bitters Through One of the Nation's Largest Beverage Alcohol Distributors
Apr 2, 2025 19:00 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
